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Objective: Prior reports suggested that infection with Helicobacter pylori  was 
associated with respiratory diseases; pathogenetic mechanisms however, were not 
defined. We tested the hypothesis that VacA, an exotoxin of Helicobacter pylori, a 
gastric pathogen, was aspirated into the lung and could stimulate secretion of 
inflammatory cytokines by lung epithelial cells. 
Methods: The presence of VacA was determined by immunohistochemistry in surgical 
lung biopsy tissue samples from 72 patients with interstitial pneumonia. The effects of 
VacA on A549 human alveolar epithelial adenocarcinoma cells and normal human 
bronchial epithelial cells were determined. After incubation with VacA, the secretions of 
cytokines were measured by Multiplex Luminex® Assays. 
Results: VacA was detected with anti-VacA antibodies in bronchial epithelial cells and 
alveolar epithelial cells from 10 of 72 patients with interstitial pneumonia. VacA was 
more prevalent in lungs of patients with collagen vascular disease-associated interstitial 
pneumonia than in those of patients with idiopathic pulmonary fibrosis, nonspecific 
interstitial pneumonia and cryptogenic organizing pneumonia. Incubation of A549 cells 
and normal human bronchial epithelial cells with VacA for 24 h was cytotoxic, and 
resulted in vacuolation. VacA induced interleukin-8 production by A549 cells and 
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normal human bronchial epithelial cells and interleukin-6 production by A549 cells. 
Based on multiplex screening, interleukin-8 and interleukin-6 were the primary 
secretory products induced by VacA.  
Conclusions: Helicobacter pylori VacA is present in human lung and can induce 
interleukin-8 and interleukin-6 production by human lung cells. VacA could have a role 
in the pathogenesis of respiratory diseases by its cytotoxic effects and by inducing the 
secretion of interleukin-8 and interleukin-6 by targeted airway epithelial cells.  
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polymyositis; DM = dermatomyositis; MCTD = mixed connective tissue disease; 
GM-CSF = granulocyte macrophage colony-stimulating factor; IFN = interferon; IL = 






Helicobacter pylori (H. pylori) has been shown to be causally related to some 
digestive diseases, such as gastritis, peptic ulcer, gastric mucosa-associated lymphoid 
tissue lymphoma, and gastric carcinoma. Recently, however, H. pylori infection has 
been reported to be associated with extra-digestive diseases [1]. A high seroprevalence 
of H. pylori was observed in patients with bronchiectasis [2] and chronic bronchitis [3]. 
Further, patients with idiopathic pulmonary fibrosis (IPF) having anti-H. pylori 
antibodies in serum showed significantly lower pulmonary function and increased 
mortality compared to patients with IPF but without anti-H. pylori antibodies in serum 
[4]. These reports suggest that H. pylori could be associated with respiratory diseases, 
however pathogenetic mechanisms for the effects of H. pylori were not defined. 
It is possible that H. pylori could be aspirated into the respiratory tract from 
oropharynx or the gastric reservoir and cause respiratory disease. This hypothesis, 
however, appears unlikely since H. pylori deoxyribonucleic acid (DNA) was not 
detected by polymerase chain reaction (PCR) in bronchoalveolar lavage fluids and lung 
tissue samples [5], and an anti-H. pylori antibody was not reactive with bronchial 
mucosa [6]. Furthermore, it appears unlikely that H. pylori could proliferate in the 
environmental conditions found in human lung. Therefore, we hypothesized that H. 
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pylori infection raises the risk of respiratory diseases indirectly, rather than directly, by 
means of systemic inflammatory and/or autoimmune responses, and/or by aspiration 
into the lung of H. pylori products, such as exotoxins. Vacuolating cytotoxin (VacA) is 
the major exotoxin of H. pylori [7,8], and induces vacuolation in the cytoplasm of 
susceptible mammalian cells. Further, VacA has pleiotropic effects on target cells, 
including membrane depolarization, mitochondrial dysfunction, autophagic process, 
activation of mitogen-activated protein kinases, inhibition of T cell function and cell 
death [9].  
We hypothesized that H. pylori VacA could be aspirated into the lung and 
stimulate secretion by lung epithelial cells of inflammatory cytokines. Here, we 
investigated the presence of VacA in human lung and whether inflammatory cytokine 
production could be induced by VacA in A549 human alveolar epithelial 






The protocol of this retrospective study was approved by the Institutional 
Review Board of Nagasaki University Hospital and the Ethics Committee, Nagasaki 
University Graduate School of Biomedical Sciences, IRB00009218. We evaluated 72 
patients with interstitial pneumonia who underwent surgical lung biopsy in Nagasaki 
University Hospital between 1983 and 2011. Twenty-two patients were diagnosed with 
IPF, 19 with nonspecific interstitial pneumonia (NSIP), 8 with cryptogenic organizing 
pneumonia (COP) and 23 with collagen vascular disease-associated interstitial 
pneumonia (CVD-IP). The idiopathic interstitial pneumonias were diagnosed according 
to the consensus criteria of the American Thoracic Society/European Respiratory 
Society [10]. The diagnoses associated with CVD-IP were rheumatoid arthritis (RA; n = 
6), systemic sclerosis (SSc; n = 5), Sjögren’s syndrome (SjS; n = 5), 
polymyositis/dermatomyositis (PM/DM; n = 3), mixed connective tissue disease 
(MCTD; n = 2), RA/SjS overlap (n = 1), and SjS/DM overlap (n = 1).  
 
Immunohistochemistry 
Immunohistochemistry was performed in 4–μm paraffin sections. The primary 
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antibodies used for the immunohistochemical studies included an anti-Helicobacter 
pylori antibody (Dako, Glostrup, Denmark) and rabbit anti-VacA antibodies, which 
were prepared as described previously [11]. Control studies were performed using rabbit 
immunoglobulin (Dako) as the primary antibodies. Immunohistochemistry was 
performed using the EnVisionTM System (Dako) according to the manufacturer’s 
instructions.  
 
Incubation of cultured cells with VacA 
A549 cells (American Type Culture Collection, Rockville, MD, USA) and 
NHBE cells (CC-2541, Lonza, Walkersville, VA, USA) were maintained in, respectively, 
Dulbecco’s modified minimal essential medium (DMEM; Invitrogen, Carlsbad, CA, 
USA) containing 10% fetal bovine serum (FBS; Invitrogen) and bronchial epithelial 
growth medium (BEGM; Lonza) in a humidified incubator (5% CO2 at 37°C).  
The toxin-producing H. pylori strain, ATCC 49503, was the source of VacA, 
which was purified as described previously [12].  
To quantify cytokine production, A549 cells were seeded in 6-well plates at a 
density of 3.0 × 105 per well and NHBE cells in 12-well plates at a density of 1.0 × 105 
per well. At subconfluence, serum-free medium was added to the wells. Cells were 
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subsequently stimulated for 3, 6, 12, and 24 h with 1, 10, 30, 60, or 120 nM VacA or 
heat-inactivated VacA (100°C, 10 min; iVacA control). These VacA concentrations have 
been used for the purpose of investigating the effects of toxin on gastric epithelial cells 
[13]. Changes in cell morphology were assessed by phase-contrast light microscopy.  
 
Cytokine levels in supernatants from cells incubated with VacA 
Cytokines in supernatants were measured by Multiplex Luminex® Assays. The 
Cytokine Human 10-Plex Panel (granulocyte macrophage colony-stimulating factor 
(GM-CSF), interferon (IFN)-γ, interleukin (IL)-1β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10 
and tumor necrosis factor (TNF)-α) was purchased from Life Technologies (LHC0001). 
96-well plates, reagents and wash solutions provided or recommended by the 
manufacturer were used and all data were analysed as recommended by the 
manufacturers. All measurements were performed in duplicate, and the values reported 
are the means of 4 experiments.  
 
Statistical analysis 
The values of continuous variables were expressed as median (range). 
Differences between 2 groups were determined by Mann-Whitney’s U-test. Differences 
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among groups were determined by one-factor analysis of variance for continuous 
variables, and Pearson's chi-square test for categorical variables, as appropriate. If a 
significant difference was found by one-factor analysis of variance, pair-wise 
comparison was performed using the Scheffë method. Statistical analysis was 
performed using Stat ViewJ-5.0 (SAS Institute, Cary, NC, USA). A p-value < 0.05 was 





Histology and immunohistochemistry 
To verify the effectiveness of the antibodies, we performed 
immunohistochemistry with anti-VacA and anti-H. pylori antibodies using gastric 
paraffin sections from patients with H. pylori infection (representative results are shown 
in Fig. 1a-c). Anti-H. pylori antibodies recognized H. pylori in gastric sections (Fig. 1b). 
Similarly, VacA was identified in H. pylori as well as in the vicinity of the bacteria (Fig. 
1c). Control studies using rabbit immunoglobulin did not reveal any immunoreactive 
cells (Data not shown).  
To identify and localize VacA in human lung tissues, we performed 
immunohistochemical analysis for VacA in lung paraffin sections from patients with 
different types of interstitial pneumonias. VacA was detected in the lung tissues in 10 of 
72 patients (13.9%) by immunohistochemistry (representative results are shown in Fig. 
1d-i). VacA was identified in alveolar epithelial cells (Fig. 1e) and in bronchial 
epithelial cells (Fig. 1h). Control studies using rabbit immunoglobulin did not reveal 
any immunoreactive cells (Fig. 1f, 1i). In this study, gastric (Fig. 1a-c) and lung tissues 




Comparison of patient characteristics between the VacA-positive and 
-negative groups 
Patient demographic data and diagnosis in the VacA–positive (n = 10) and 
VacA–negative (n = 62) groups are shown in Table 1. The diagnoses of VacA–positive 
cases were IPF (n = 1), NSIP (n = 2) and CVD-IP (n = 7). The diagnoses of collagen 
vascular diseases in the VacA–positive group included SjS (n = 2), and PM/DM, SSc, 
RA, MCTD, and SjS/DM overlap (n = 1, respectively). There was a significant 
difference in the diagnoses between the 2 groups (p=0.04), VacA was more prevalent in 
the lungs of patients with CVD-IP than those of patients with IPF, NSIP and COP. 
Detailed chart review revealed that there were no significant differences in other clinical 
characteristics, including survival, results of pulmonary function tests, arterial blood gas 




Incubation of A549 and NHBE cells with 120nM VacA resulted in vacuolation 
(Fig. 2a, 2c), which was not observed in cells incubated with 120 nM iVacA (Fig. 2b, 




VacA-induced cytokine production 
A549 and NHBE cells were incubated with 120 nM VacA or iVacA for 24 h. As 
shown in Fig. 3a, after a 24-h incubation with 120 nM VacA or iVacA, 1.9- and 3.6-fold 
increase were observed in IL-8 and IL-6 concentrations in the medium of A549 cells, 
respectively. IL-1β and GM-CSF production were also induced by VacA although these 
were only a slight induction. After a 24-h incubation with 120 nM VacA or iVacA, 
17.2-fold increase was observed in IL-8 concentration in the medium of NHBE cells 
(Fig. 3b).  
A549 cells were incubated with the indicated concentrations of VacA or iVacA 
(0–120 nM) for 24 h, VacA increased IL-8 (Fig. 4a) and IL-6 (Fig. 4b) in a 
concentration-dependent manner. Additionally, A549 cells were incubated with 120 nM 
VacA or iVacA for the indicated times (0–24 h). Stimulation with 120 nM VacA resulted 
in a time-dependent increase in IL-8 (Fig. 4d) and IL-6 (Fig. 4e) production. Regarding 
IL-1β and GM-CSF, there were no concentration- and time-dependent changes (Data 
not shown).  
NHBE cells were also incubated with the indicated concentrations of VacA or 
iVacA (0–120 nM) for 24 h and with 120 nM VacA or iVacA for the indicated times (0–
15 
 
24 h). VacA increased IL-8 in a concentration- (Fig. 4c) and time-dependent manner 





This is the first study to demonstrate that H. pylori VacA is present in human 
lung tissues and that VacA induces IL-8 production by A549 and NHBE cells and IL-6 
production by A549 cells. The present study also showed that VacA was more prevalent 
in lungs of patients with CVD-IP than those of patients with IPF, NSIP and COP. 
Association between respiratory diseases and gastro-esophageal reflux (GER) 
has long been recognized [14]. GER has been documented to be highly prevalent in 
patients with a variety of lung diseases including patients with IPF, cystic fibrosis and 
CVDs [15]. Chronic microaspiration (i.e., tracheobronchial aspiration of small amounts 
of gastric secretions) secondary to GER has been hypothesized to cause repetitive 
subclinical injury to the lung, leading to pulmonary fibrosis [16]. Previous reports 
showed the presence of high levels of pepsin [17-21] and bile acids [22,23] in the 
bronchoalveolar lavage fluid of patients with lung transplants and children with GER or 
cystic fibrosis, suggesting that gastric contents could be aspirated into the lung by 
microaspiration without any distinct clinical episode. It has been suggested that pepsin 
or bile acids aspirated through GER may be a potential contributor to lung allograft 
dysfunction [20-22]. Moreover, suppression of GER in patients with IPF was associated 
with a smaller decrease in forced vital capacity [24] and a lower radiological fibrosis 
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score on high-resolution computed tomography, and was an independent predictor of 
longer survival [25]. Other substances in gastric juice as yet unidentified may also 
contribute to the pathogenesis of respiratory dysfunction and disease. Numerous studies 
have also shown that H. pylori can be detected in dental plaque and saliva of human 
subjects, suggesting that the oral cavity may be an extra-gastric reservoir of H. pylori 
[26]. These findings suggest that VacA could be aspirated into the lung from stomach 
and/or oral cavity. In fact, in the present study, VacA was detected in the bronchial and 
alveolar epithelial cells, which are easily accessible following aspiration. Further studies 
are needed to elucidate the VacA entering mechanisms. 
VacA is known to cause vacuoles in human gastric cancer cell lines AZ-521 
and AGS, but not in human promyeloblastic cell line HL-60 [11], VacA-induced 
vacuolation thus appears to be cell-type specific. We showed that VacA causes vacuoles 
in A549 and NHBE cells. In addition, vacuolation were not observed with 
heat-inactivated VacA, indicating that these vacuolation were specific to the native 
VacA protein. However, there was no evidence of vacuolation in VacA immunoreactive 
cells in human lung tissues and clinical significance of this phenomenon still remains 
unknown. 
Because of its prevalence and ability to affect human immune function, many 
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researchers have hypothesized that H. pylori might contribute to the systemic rheumatic 
diseases development. Previous reports have suggested a positive relationship between 
H. pylori infection and various autoimmune diseases [27]. Some evidences suggest that 
eradication of H. pylori may lead to an improvement of autoimmune disorders, such as 
immune thrombocytopenia [28], SSc [29] and autoimmune thyroid disease [30]. The 
present study showed that VacA was more prevalent in lungs of patients with CVD-IP 
than that of patients with IPF, NSIP and COP. Although the exact role of H. pylori in the 
pathogenesis of these diseases is still unclear, these findings imply the possible 
association of H. pylori and autoimmune disorders.  
In the present study, we investigated whether several kinds of cytokines 
(GM-CSF, IFN-γ, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10 and TNF-α) could be 
induced in A549 and NHBE cells by VacA. Interestingly, VacA induced IL-8 production 
by A549 and NHBE cells and IL-6 production by A549 cells. Other cytokines were not 
induced by VacA. These findings suggest that induction of IL-8 and IL-6 in airway 
epithelial cells are specific reaction against VacA stimulation. IL-8 is expressed in a 
variety of inflammatory respiratory diseases, including IPF [31], CVD-IP [32] and 
bronchiectasis [33]. Interestingly, increased plasma IL-8 levels were associated with 
significantly worse outcomes in IPF [31]. IL-6 is also known to induce interstitial 
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pneumonia [34-36]. The prolonged interaction between the VacA and lung epithelial 
cells could trigger the release of inflammatory mediators and consequently lead to 
respiratory disease in predisposed individuals. 
Some limitations to this study should be noted. The most important limitation 
of this study is that only 72 patients were enrolled. We were also not able to evaluate the 
serum H. pylori antibodies and the concentrations of IL-8 and IL-6 in bronchoalveolar 
lavage fluid in the enrolled patients because the volume of preserved samples was not 
sufficient. Further clinical studies involving larger cohorts of patients are warranted to 
elucidate whether VacA was associated with the pathogenesis of pulmonary diseases 
and CVDs. 
In conclusion, our identification of VacA in human lung tissues of patients with 
interstitial pneumonia, and the demonstration that VacA induced vacuolation and 
production of IL-8 and IL-6 by airway epithelial cells, together with previous reports of 
a high H. pylori seroprevalence in several types of respiratory diseases, suggest that 
VacA could play a role in the pathogenesis of respiratory diseases and/or CVDs. Further 
studies of the immunological response to H. pylori VacA and its role in the pathogenesis 
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Figure 1. Photomicrographs of histological and immunohistochemical studies of 
representative gastric and surgical lung biopsy specimens 
a–c are sequential sections. a: Hematoxylin-eosin staining. b: Immunohistochemistry 
with anti-Helicobacter pylori antibody. c: Immunohistochemistry with anti-VacA 
antibody. Arrows show VacA. Scale bar: = 200 μm.  
d–f and g–i are sequential sections obtained from 2 patients. Lung tissues in d-f and 
gastric tissues in a-c were obtained from the same patient. d, g: hematoxylin-eosin 
staining. e, h: immunohistochemistry with anti-VacA antibody. Arrows show VacA. f, i: 
control studies using rabbit immunoglobulin as the primary antibodies. Scale bar: = 400 
μm. 
 
Figure 2. VacA-induced vacuolation 
Cells were incubated with 120nM of VacA or heat-inactivated VacA (iVacA, control) for 
24 h; incubation with 120nM-VacA resulted in vacuolation of A549 cells (a) and normal 
human bronchial epithelial (NHBE) cells (c). Vacuolation were not observed in cells 




Figure 3. VacA-induced cytokine production 
a: A549 cells were incubated with 120 nM VacA or heat-inactivated VacA (iVacA, 
control) for 24 h. After a 24-h incubation with 120 nM VacA or iVacA, 1.9- and 3.6-fold 
increase were observed in IL-8 and IL-6 concentrations in the medium of A549 cells, 
respectively. b: Normal human bronchial epithelial (NHBE) cells were incubated with 
120 nM VacA or iVacA for 24 h. After a 24-h incubation with 120 nM VacA or iVacA, 
17.2-fold increase was observed in IL-8 concentration in the medium of NHBE cells. 
All measurements were performed in duplicate, and the values reported are the means of 
4 experiments. Statistical significance: #, p < 0.05. 
 
Figure 4. VacA-induced IL-8 and IL-6 production 
a-c: A549 cells and normal human bronchial epithelial (NHBE) cells were incubated 
with the indicated concentrations of VacA (■) or heat-inactivated VacA (iVacA, control, 
□) for 24 h (0–120 nM); incubation with VacA for 24 h resulted in 
concentration-dependent increases in IL-8 (a) and IL-6 (b) in the medium of A549 cells 
and IL-8 (c) in that of NHBE cells. * denotes a statistically significant difference as 
compared with 0, 1, 10, or 30 nM VacA and 120 nM iVacA (p < 0.05), † with 0, 1, or 10 
nM VacA and 120 nM iVacA (p < 0.05), # with 0, 1, 10, 30, 60 nM VacA and 120 nM 
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iVacA (p < 0.05), ¶ with 0, 1, 10 nM VacA and 60 nM iVacA (p < 0.05) and § with 30 
nM iVacA (p < 0.05). d-f: A549 and NHBE cells were incubated with 120nM VacA (■) 
or iVacA (□) for the indicated times (0–24 h). There were time-dependent increases in 
IL-8 (d) and IL-6 (e) contents in the supernatants of A549 cells and IL-8 (f) in that of 
NHBE cells following incubation with 120 nM VacA. ** denotes a statistically 
significant difference as compared with 0, 3, 6 h with VacA and 24 h with iVacA (p < 
0.05), ‡ with 0, 3, 6 h with VacA and 24 h with iVacA (p < 0.05), ## with 0, 3, 6,12 h 
VacA and 24 h iVacA (p < 0.05) and ¶¶ with 0, 3, 6 h VacA and 12 h iVacA (p < 0.05). 
All measurements were performed in duplicate, and the values reported are the means of 





Table 1. Comparison of patient characteristics by immunohistochemistry between 
the VacA–positive and –negative groups. 
 
VacA–positive VacA–negative P-value 
Subjects 10 62 
 
Age (years) 54.5 (40–69) 60 (28–74) NS 




 IPF 1 21  
 NSIP 2 17  
 COP 0 8  
 
CVD-IP 7 16 
 
IPF: idiopathic pulmonary fibrosis, NSIP: nonspecific interstitial pneumonia, COP: 
















































































































































































Time with 120nM-VacA [hr] Time with 120nM-VacA [hr]
